OpenVSafe by OpenVAERS
Search V-safe

98W-34089-77621

1 vaccination 2 coded responses 2 check-ins 2 free-text entries 0 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
151 / PA
Registered
2021-05-01
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-13
    Dose 1 — Pfizer-BioNTech
  2. 2021-05-01
    Registered in v-safe
  3. 2021-05-01
    Survey response — day 14, dose 1
    MedDRA: Dysmenorrhoea, Loss of personal independence in daily activities, Nausea — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities
    Free text: Extreme pain during menstral cycle. Unusual and intense cramping that was so severe I could not function. This was unlike any period I have experienced before. I normally have cramping and back pain, but this had me in bed all day, felt nausiated.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-07-13
    Survey response — 3 months, dose 1
    MedDRA: Heavy menstrual bleeding, Menstruation irregular — Feeling: Good
    Free text: Change in menstrual cycle. Heavier than normal blood flow for the last 3 periods. Periods usually last 3 days and are now lasting 5 with heavier blood flow. This has been true for my last 3 cycles since I got the vaccine.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-04-13Pfizer-BioNTech

Free text

Release 8 — day 14, dose 1

2021-05-01

Symptoms: Extreme pain during menstral cycle. Unusual and intense cramping that was so severe I could not function. This was unlike any period I have experienced before. I normally have cramping and back pain, but this had me in bed all day, felt nausiated.

Release 9 — 3 months, dose 1

2021-07-13

Symptoms: Change in menstrual cycle. Heavier than normal blood flow for the last 3 periods. Periods usually last 3 days and are now lasting 5 with heavier blood flow. This has been true for my last 3 cycles since I got the vaccine.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDDysmenorrhoea ✓ ✓ ✓
SDHeavy menstrual bleeding ✓ ✓ ✓
SDLoss of personal independence in daily activities ✓ ✓ ✓
SDMenstruation irregular ✓ ✓ ✓
SDNausea ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release